Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
It provides Covid-19 detection and Omicron surveillance in less than two hours
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Narayanan to lead SeQuent through next phase of consolidation and growth
The last date to apply for this program is 18th January 2022
The study will be published on the pre-print server, medRXiv, shortly
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
Subscribe To Our Newsletter & Stay Updated
